Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient Outcomes

<i>Background and Objectives</i>: Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and is the third leading cause of cancer-related deaths. In 2020 alone, there were over 1.9 million new cases of CRC and nearly 0.9 million deaths worldwide. The incidence and outc...

Full description

Saved in:
Bibliographic Details
Main Authors: Walid Shalata, Alexander Gluzman, Sofia Man, Ahron Yehonatan Cohen, Ashraf Abu Jama, Itamar Gothelf, Lena Tourkey, Ala Eddin Neime, Ali Abu Juma’a, Keren Peri-Hanania, Oshri Machluf, Gal Shoham Levin, Sondos Shalata, Ahab Hayadri, Ez El Din Abu Zeid, Nashat Abu Yasin, Amichay Meirovitz, Alexander Yakobson
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/60/12/1951
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846103747727458304
author Walid Shalata
Alexander Gluzman
Sofia Man
Ahron Yehonatan Cohen
Ashraf Abu Jama
Itamar Gothelf
Lena Tourkey
Ala Eddin Neime
Ali Abu Juma’a
Keren Peri-Hanania
Oshri Machluf
Gal Shoham Levin
Sondos Shalata
Ahab Hayadri
Ez El Din Abu Zeid
Nashat Abu Yasin
Amichay Meirovitz
Alexander Yakobson
author_facet Walid Shalata
Alexander Gluzman
Sofia Man
Ahron Yehonatan Cohen
Ashraf Abu Jama
Itamar Gothelf
Lena Tourkey
Ala Eddin Neime
Ali Abu Juma’a
Keren Peri-Hanania
Oshri Machluf
Gal Shoham Levin
Sondos Shalata
Ahab Hayadri
Ez El Din Abu Zeid
Nashat Abu Yasin
Amichay Meirovitz
Alexander Yakobson
author_sort Walid Shalata
collection DOAJ
description <i>Background and Objectives</i>: Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and is the third leading cause of cancer-related deaths. In 2020 alone, there were over 1.9 million new cases of CRC and nearly 0.9 million deaths worldwide. The incidence and outcomes of CRC exhibit significant geographical and temporal variations, largely influenced by diverse risk factors among populations. Recognizing the prognostic factors and the presenting symptoms of CRC, a leading global cancer with high mortality, can enhance early detection and thereby improve clinical outcomes. <i>Materials and Methods</i>: This retrospective, observational study analyzed 724 CRC elderly patients aged 70 and over (median age 80, 53.17% male), treated at a single center. Data on demographics, clinical characteristics, and outcomes were collected. Overall survival was analyzed using Kaplan–Meier curves, with stratification based on tumor location, disease staging, lymph node involvement, and family history. <i>Results</i>: Our study encompassed all CRC cases treated with surgery and systemic therapies (chemotherapy or biological agents) from July 2002 to September 2020. We focused on comparing prognosis between left-sided and right-sided CRC, as well as rectal cancer. We found that left-sided CRC demonstrated a superior prognosis compared to rectal cancer (<i>p</i> = 0.0022). Furthermore, among patients with CRC, tumors originating in the rectum were associated with worse outcomes compared to those arising in both the right and left colon, regardless of disease stage (<i>p</i> = 0.0049). Additionally, a family history of CRC was associated with poorer prognosis, impacting both metastatic (<i>p</i> = 0.0022) and localized disease (<i>p</i> = 0.035). The main symptoms prompting patients to start an investigation of CRC were abdominal pain (31.49%), anemia (18.08%), rectal bleeding (hematochezia) (17.82%), change in bowel habits (9.94%), and weight loss (7.60%). <i>Conclusions</i>: This study provides valuable insights into the symptoms prompting initial investigation and the prognostic factors associated with CRC in an elderly population with varied characteristics. It underscores the need for increased vigilance in recognizing key symptoms and the importance of personalized treatment strategies tailored to these prognostic factors.
format Article
id doaj-art-d0e5be1ff76c414aa9161d5c4a31c20e
institution Kabale University
issn 1010-660X
1648-9144
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj-art-d0e5be1ff76c414aa9161d5c4a31c20e2024-12-27T14:38:37ZengMDPI AGMedicina1010-660X1648-91442024-11-016012195110.3390/medicina60121951Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient OutcomesWalid Shalata0Alexander Gluzman1Sofia Man2Ahron Yehonatan Cohen3Ashraf Abu Jama4Itamar Gothelf5Lena Tourkey6Ala Eddin Neime7Ali Abu Juma’a8Keren Peri-Hanania9Oshri Machluf10Gal Shoham Levin11Sondos Shalata12Ahab Hayadri13Ez El Din Abu Zeid14Nashat Abu Yasin15Amichay Meirovitz16Alexander Yakobson17The Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, IsraelThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, IsraelThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, IsraelThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, IsraelThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, IsraelGoldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, IsraelThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, IsraelMedical School for International Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, IsraelMedical School for International Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, IsraelPhaseV Trials Ltd., Tel Aviv 67443, IsraelPhaseV Trials Ltd., Tel Aviv 67443, IsraelPhaseV Trials Ltd., Tel Aviv 67443, IsraelNutrition Unit, Galilee Medical Center, Nahariya 22000, IsraelMedical School for International Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, IsraelMedical School for International Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, IsraelThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, IsraelThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, IsraelThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel<i>Background and Objectives</i>: Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and is the third leading cause of cancer-related deaths. In 2020 alone, there were over 1.9 million new cases of CRC and nearly 0.9 million deaths worldwide. The incidence and outcomes of CRC exhibit significant geographical and temporal variations, largely influenced by diverse risk factors among populations. Recognizing the prognostic factors and the presenting symptoms of CRC, a leading global cancer with high mortality, can enhance early detection and thereby improve clinical outcomes. <i>Materials and Methods</i>: This retrospective, observational study analyzed 724 CRC elderly patients aged 70 and over (median age 80, 53.17% male), treated at a single center. Data on demographics, clinical characteristics, and outcomes were collected. Overall survival was analyzed using Kaplan–Meier curves, with stratification based on tumor location, disease staging, lymph node involvement, and family history. <i>Results</i>: Our study encompassed all CRC cases treated with surgery and systemic therapies (chemotherapy or biological agents) from July 2002 to September 2020. We focused on comparing prognosis between left-sided and right-sided CRC, as well as rectal cancer. We found that left-sided CRC demonstrated a superior prognosis compared to rectal cancer (<i>p</i> = 0.0022). Furthermore, among patients with CRC, tumors originating in the rectum were associated with worse outcomes compared to those arising in both the right and left colon, regardless of disease stage (<i>p</i> = 0.0049). Additionally, a family history of CRC was associated with poorer prognosis, impacting both metastatic (<i>p</i> = 0.0022) and localized disease (<i>p</i> = 0.035). The main symptoms prompting patients to start an investigation of CRC were abdominal pain (31.49%), anemia (18.08%), rectal bleeding (hematochezia) (17.82%), change in bowel habits (9.94%), and weight loss (7.60%). <i>Conclusions</i>: This study provides valuable insights into the symptoms prompting initial investigation and the prognostic factors associated with CRC in an elderly population with varied characteristics. It underscores the need for increased vigilance in recognizing key symptoms and the importance of personalized treatment strategies tailored to these prognostic factors.https://www.mdpi.com/1648-9144/60/12/1951colorectal cancerelderlyprognostic factorssurvivaldiagnostic symptomsretrospective study
spellingShingle Walid Shalata
Alexander Gluzman
Sofia Man
Ahron Yehonatan Cohen
Ashraf Abu Jama
Itamar Gothelf
Lena Tourkey
Ala Eddin Neime
Ali Abu Juma’a
Keren Peri-Hanania
Oshri Machluf
Gal Shoham Levin
Sondos Shalata
Ahab Hayadri
Ez El Din Abu Zeid
Nashat Abu Yasin
Amichay Meirovitz
Alexander Yakobson
Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient Outcomes
Medicina
colorectal cancer
elderly
prognostic factors
survival
diagnostic symptoms
retrospective study
title Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient Outcomes
title_full Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient Outcomes
title_fullStr Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient Outcomes
title_full_unstemmed Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient Outcomes
title_short Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient Outcomes
title_sort colorectal cancer in elderly patients insights into presentations prognosis and patient outcomes
topic colorectal cancer
elderly
prognostic factors
survival
diagnostic symptoms
retrospective study
url https://www.mdpi.com/1648-9144/60/12/1951
work_keys_str_mv AT walidshalata colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT alexandergluzman colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT sofiaman colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT ahronyehonatancohen colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT ashrafabujama colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT itamargothelf colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT lenatourkey colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT alaeddinneime colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT aliabujumaa colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT kerenperihanania colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT oshrimachluf colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT galshohamlevin colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT sondosshalata colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT ahabhayadri colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT ezeldinabuzeid colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT nashatabuyasin colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT amichaymeirovitz colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes
AT alexanderyakobson colorectalcancerinelderlypatientsinsightsintopresentationsprognosisandpatientoutcomes